Detailed information for compound 416864

Basic information

Technical information
  • TDR Targets ID: 416864
  • Name: N-[4-[5-(4-fluorophenyl)-3-(3-hydroxypropyl)- 2-(3-morpholin-4-yl-3-oxopropyl)sulfanylimida zol-4-yl]pyridin-2-yl]acetamide
  • MW: 527.611 | Formula: C26H30FN5O4S
  • H donors: 2 H acceptors: 5 LogP: 1.39 Rotable bonds: 12
    Rule of 5 violations (Lipinski): 2
  • SMILES: OCCCn1c(SCCC(=O)N2CCOCC2)nc(c1c1ccnc(c1)NC(=O)C)c1ccc(cc1)F
  • InChi: 1S/C26H30FN5O4S/c1-18(34)29-22-17-20(7-9-28-22)25-24(19-3-5-21(27)6-4-19)30-26(32(25)10-2-13-33)37-16-8-23(35)31-11-14-36-15-12-31/h3-7,9,17,33H,2,8,10-16H2,1H3,(H,28,29,34)
  • InChiKey: LIBAEMASHSHFFV-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • N-[4-[5-(4-fluorophenyl)-3-(3-hydroxypropyl)-2-(3-morpholino-3-oxo-propyl)sulfanyl-imidazol-4-yl]-2-pyridyl]acetamide
  • N-[4-[5-(4-fluorophenyl)-3-(3-hydroxypropyl)-2-[(3-morpholino-3-oxopropyl)thio]-4-imidazolyl]-2-pyridyl]acetamide
  • N-[4-[5-(4-fluorophenyl)-3-(3-hydroxypropyl)-2-(3-morpholin-4-yl-3-oxo-propyl)sulfanyl-imidazol-4-yl]pyridin-2-yl]ethanamide
  • N-[4-[5-(4-fluorophenyl)-3-(3-hydroxypropyl)-2-[(3-keto-3-morpholino-propyl)thio]imidazol-4-yl]-2-pyridyl]acetamide

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens mitogen-activated protein kinase 14 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma japonicum ko:K04441 p38 MAP kinase, putative Get druggable targets OG5_128610 All targets in OG5_128610
Trypanosoma brucei gambiense mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus multilocularis mitogen activated protein kinase 11 Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania donovani mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Trypanosoma congolense mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Candida albicans MAP kinase involved in osmoregulation Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania infantum mitogen-activated protein kinase 3, putative,map kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Trypanosoma cruzi mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Brugia malayi P38 map kinase family protein 2 Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania major mitogen-activated protein kinase 3, putative,map kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Candida albicans MAP kinase involved in osmoregulation Get druggable targets OG5_128610 All targets in OG5_128610
Trypanosoma cruzi mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania braziliensis mitogen-activated protein kinase 3, putative,map kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus multilocularis mitogen activated protein kinase 11 Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus granulosus mitogen activated protein kinase 14 Get druggable targets OG5_128610 All targets in OG5_128610
Loa Loa (eye worm) CMGC/MAPK/P38 protein kinase Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus granulosus mitogen activated protein kinase 11 Get druggable targets OG5_128610 All targets in OG5_128610
Trypanosoma brucei mitogen-activated protein kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus multilocularis mitogen activated protein kinase 14 Get druggable targets OG5_128610 All targets in OG5_128610
Leishmania mexicana mitogen-activated protein kinase 3, putative,map kinase 3, putative Get druggable targets OG5_128610 All targets in OG5_128610
Echinococcus multilocularis mitogen activated protein kinase 14 Get druggable targets OG5_128610 All targets in OG5_128610
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Trypanosoma brucei mitogen-activated protein kinase 5 mitogen-activated protein kinase 14 360 aa 336 aa 33.3 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus multilocularis mitogen activated protein kinase 14 0.0152 0 0.5
Echinococcus granulosus mitogen activated protein kinase 11 0.0152 0 0.5
Echinococcus multilocularis mitogen activated protein kinase 11 0.0152 0 0.5
Leishmania major malonyl-coa decarboxylase-like protein 0.0722 0.3382 1
Trypanosoma brucei malonyl-CoA decarboxylase, mitochondrial precursor, putative 0.0722 0.3382 1
Trypanosoma cruzi malonyl-CoA decarboxylase, mitochondrial precursor, putative 0.0722 0.3382 1
Loa Loa (eye worm) hypothetical protein 0.1839 1 1
Echinococcus multilocularis mitogen activated protein kinase 14 0.0152 0 0.5
Wolbachia endosymbiont of Brugia malayi malonyl-CoA decarboxylase 0.1839 1 0.5
Echinococcus multilocularis mitogen activated protein kinase 11 0.0152 0 0.5
Trypanosoma cruzi malonyl-CoA decarboxylase, mitochondrial precursor, putative 0.0722 0.3382 1
Echinococcus granulosus mitogen activated protein kinase 14 0.0152 0 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 9.501 uM Inhibition of mitogen-activated protein kinase p38 alpha ChEMBL. 15566301
IC50 (binding) = 9.501 uM Inhibition of mitogen-activated protein kinase p38 alpha ChEMBL. 15566301

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.